Cargando…
The impact of pharmaceutical innovation on premature cancer mortality in Canada, 2000–2011
The premature cancer mortality rate has been declining in Canada, but there has been considerable variation in the rate of decline across cancer sites. I analyze the effect that pharmaceutical innovation had on premature cancer mortality in Canada during the period 2000–2011, by investigating whethe...
Autor principal: | Lichtenberg, Frank R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6116915/ https://www.ncbi.nlm.nih.gov/pubmed/27878681 http://dx.doi.org/10.1007/s10754-015-9172-2 |
Ejemplares similares
-
The impact of pharmaceutical innovation on the burden of disease in Canada, 2000–2016
por: Lichtenberg, Frank R.
Publicado: (2019) -
The impact of pharmaceutical innovation on the burden of disease in Ireland, 2000–2015
por: Lichtenberg, Frank R
Publicado: (2020) -
Premature Deaths Among Children with Epilepsy — South Carolina, 2000–2011
por: Selassie, Anbesaw W., et al.
Publicado: (2014) -
Number of drugs provided by the Pharmaceutical Benefits Scheme and mortality and hospital utilization in Australia, 2002–2019
por: Lichtenberg, Frank R.
Publicado: (2023) -
Educational inequalities in premature mortality by region in the Belgian population in the 2000s
por: Renard, Françoise, et al.
Publicado: (2017)